Search

Philip J Gotwals

age ~61

from Needham, MA

Get Report
Also known as:
  • Philip Joyce Gotwals
  • Philip L Gotwals
  • Phil J Gotwals
  • Phillip J Gotwals
  • Phil L Gotwals
  • Phillip L Gotwals
  • Philip S
Phone and address:
221 Elmwood Rd, Needham, MA 02492
781 453-0405
Related to:
Connected to:

Philip Gotwals Phones & Addresses

  • 221 Elmwood Rd, Needham, MA 02492 • 781 453-0405
  • 45 Plymouth Rd, Needham, MA 02492 • 781 453-0405
  • Stonington, ME
  • Boston, MA
  • Auburndale, MA
  • Northampton, MA
  • Ellsworth, ME
  • 221 Elmwood Rd, Needham, MA 02492 • 617 470-5462

Work

  • Position:
    Professional/Technical

Education

  • Degree:
    Graduate or professional degree

Us Patents

  • Method For The Treatment Of Inflammatory Disorders

    view source
  • US Patent:
    6955810, Oct 18, 2005
  • Filed:
    Nov 30, 2001
  • Appl. No.:
    09/996738
  • Inventors:
    Philip Gotwals - Needham MA, US
    Antonin DeFougerolles - Brookline MA, US
    Roy Lobb - Westwood MA, US
    Victor Kotelianski - Boston MA, US
  • Assignee:
    Biogen Idec, Inc. - Cambridge MA
  • International Classification:
    A61K039/395
    C07K016/28
  • US Classification:
    4241441, 4241521, 53038822
  • Abstract:
    A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.

  • Method For The Treatment Of Inflammatory Disorders

    view source
  • US Patent:
    7462353, Dec 9, 2008
  • Filed:
    Apr 18, 2005
  • Appl. No.:
    11/108581
  • Inventors:
    Philip Gotwals - Needham MA, US
    Antonin DeFougerolles - Brookline MA, US
    Roy Lobb - Westwood MA, US
  • Assignee:
    Biogen Idec MA Inc. - Cambridge MA
  • International Classification:
    A61K 39/395
    C07K 16/28
  • US Classification:
    4241441, 4241521, 53038822
  • Abstract:
    A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.

  • Method For The Treatment Of Inflammatory Disorders

    view source
  • US Patent:
    8084031, Dec 27, 2011
  • Filed:
    Nov 11, 2008
  • Appl. No.:
    12/268459
  • Inventors:
    Philip Gotwals - Needham MA, US
    Antonin De Fougerolles - Brookline MA, US
    Roy Lobb - Westwood MA, US
    Victor Kotelianski - Boston MA, US
  • Assignee:
    Biogen Idec MA Inc. - Cambridge MA
  • International Classification:
    A61K 39/395
    C07K 16/28
  • US Classification:
    4241441, 4241521, 5303882
  • Abstract:
    A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.

  • Method For The Treatment Of Inflammatory Disorders

    view source
  • US Patent:
    8557240, Oct 15, 2013
  • Filed:
    Nov 15, 2011
  • Appl. No.:
    13/296778
  • Inventors:
    Philip Gotwals - Needham MA, US
    Antonin de Fougerolles - Brookline MA, US
    Roy Lobb - Westwood MA, US
    Victor E. Kotelianski - Boston MA, US
  • Assignee:
    Biogen IDEC MA Inc. - Cambridge MA
  • International Classification:
    A61K 39/395
  • US Classification:
    4241301, 4241411, 4241431, 4241521, 4241531
  • Abstract:
    A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.

  • Variant Type Ii Tgf-Beta Receptor Fusion Proteins And Methods

    view source
  • US Patent:
    20020004037, Jan 10, 2002
  • Filed:
    Dec 11, 2000
  • Appl. No.:
    09/734300
  • Inventors:
    Philip Gotwals - Needham MA, US
    Richard Cate - Cohasset MA, US
  • International Classification:
    C12P021/02
    C12N005/06
    A61K038/19
  • US Classification:
    424/085100, 514/012000, 435/069500, 435/325000, 530/351000
  • Abstract:
    Fusion proteins comprising a variant form of TGF-beta Type II receptor linked to a portion of an immunoglobulin constant chain are described. Also described are methods of using the fusion proteins of the invention to treat a variety of fibroproliferative disorders.

  • Method For The Treatment Of Fibrosis

    view source
  • US Patent:
    20020182213, Dec 5, 2002
  • Filed:
    Feb 1, 2002
  • Appl. No.:
    10/061658
  • Inventors:
    Philip Gotwals - Needham MA, US
    Victor Kotelianski - Boston MA, US
  • International Classification:
    A61K039/395
  • US Classification:
    424/146100, 424/143100
  • Abstract:
    Disclosed is a method of treating fibrosis in a human or animal subject. The method comprises administering to the subject an effective amount of an antibody to an integrin or fragment thereof.

  • Global Expression Analysis Of Extracellular Matrix-Integrin Interactions In Monocytes

    view source
  • US Patent:
    20030124726, Jul 3, 2003
  • Filed:
    Aug 3, 2001
  • Appl. No.:
    09/924168
  • Inventors:
    Antonin deFougerolles - Brookline MA, US
    Philip Gotwals - Needham MA, US
    Cynthia Green - Madison CT, US
  • International Classification:
    C12N015/87
    A61K048/00
  • US Classification:
    435/455000, 514/044000
  • Abstract:
    Disclosed are methods of identifying integrin modulating agents using differential gene expression. Also disclosed are method of treating atheroscerosis and inflammatory disorders in a subject.

  • Method For The Treatment Of Fibrosis

    view source
  • US Patent:
    20040037827, Feb 26, 2004
  • Filed:
    Jul 22, 2003
  • Appl. No.:
    10/625260
  • Inventors:
    Philip Gotwals - Needham MA, US
    Victor Kotelianski - Boston MA, US
  • International Classification:
    A61K039/395
  • US Classification:
    424/144100, 424/141100
  • Abstract:
    Disclosed is a method of treating fibrosis in a human or animal subject. The method comprises administering to the subject an effective amount of an antibody to an integrin or fragment thereof.

Resumes

Philip Gotwals Photo 1

Global Head, Business Development And Licensing

view source
Location:
Needham, MA
Industry:
Pharmaceuticals
Work:
Novartis Institutes For Biomedical Research (Nibr)
Global Head, Business Development and Licensing
Novartis
Executive Director, Oncology Research
Altus Group Sep 2006 - Mar 2009
Vice President, Program Management
Biogen Sep 1994 - Sep 2006
Senior Director, Program and Alliance Management
Education:
University of California, Berkeley 1987 - 1992
Doctorates, Doctor of Philosophy, Genetics Amherst College 1982 - 1985
Bachelors, Bachelor of Arts, Biology Northampton High School
University of Cali
Skills:
Research
Oncology
Philip Gotwals Photo 2

Executive Director, Oncology Research

view source
Position:
Executive Director, Oncology Research Collaborations at Novartis
Location:
Greater Boston Area
Industry:
Pharmaceuticals
Work:
Novartis since Apr 2009
Executive Director, Oncology Research Collaborations
Altus Sep 2006 - Mar 2009
Vice President, Program Management
Biogen Idec Sep 1994 - Sep 2006
Senior Director, Program and Alliance Management
Education:
University of California, Berkeley 1987 - 1992
PhD, Genetics Amherst College 1982 - 1985
BA, Biology

Youtube

2016 New Directions in Cancer Care For Nonspe...

2016 New Directions in Cancer Care For Nonspeciali...

... Harvard Medical School Dr. Philip Gotwals Executive Director, Expl...

  • Duration:
    3h 23m 43s

Targeting Cancer Pathways: Understanding Immu...

Targeting Cancer Pathways: Understanding Immune Ch...

Participating Experts: James Allison, PhD, (MD Anderson), Gordon J. Fr...

  • Duration:
    1h 44s

Timeless Music | Philip Glass & Arturo Bejar ...

Timeless Music | Philip Glass & Arturo Bejar | Tal...

Lecture, conversation, and performance with Philip Glass and Arturo Be...

  • Duration:
    1h 29m 18s

S1E2 Global Developments

S1E2 Global Developments

Our Morning Coffee Series proposes to take just ten minutes of your ti...

  • Duration:
    11m 8s
Get Report for Philip J Gotwals from Needham, MA, age ~61
Control profile